Your session is about to expire
← Back to Search
SAFE Intervention for Suicide (IAMSAFE Trial)
IAMSAFE Trial Summary
This trial aims to prevent suicide among Canadian youth, which is currently the leading cause of death for them. The researchers will be testing a suicide prevention intervention that has been used before, to see if it
IAMSAFE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIAMSAFE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IAMSAFE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Which specific criteria must individuals meet in order to qualify for enrollment in this medical study?
"To be eligible for inclusion in this clinical trial, potential subjects must exhibit behavioral symptoms and fall within the age range of 12 to 17 years old. The study aims to recruit a total of 330 participants."
Are participants currently being recruited for this ongoing medical study?
"As per the information available on clinicaltrials.gov, this ongoing clinical trial is actively seeking eligible candidates. The trial was initially posted for recruitment on March 1st, 2021 and has recently been updated as of January 25th, 2024."
Can you confirm if this medical study is being conducted at multiple facilities within the state?
"Trillium Health Partners in Mississauga, The Hospital for Sick Children in Toronto, and Alberta Children's Hospital - Alberta Health Services & University of Calgary in Calgary are among the 4 sites actively recruiting patients. Additionally, there are 4 other locations participating in patient recruitment for this trial."
Is there an age limit that would exclude individuals who are above the age of 40 from participating in this medical study?
"For this research study, individuals between the ages of 12 and 17 are eligible to participate."
Share this study with friends
Copy Link
Messenger